Clinical Trials List
Protocol Number20110114
Not yet recruiting
2012-12-01 - 2014-06-30
Phase III
Terminated3
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- JYH-MING JIMMY JUANG Division of Cardiovascular Diseases
- CHO-KAI WU Division of Cardiovascular Diseases
- Juey-Jen Hwang Division of Cardiovascular Diseases
- CHIA-TI TSAI Division of Cardiovascular Diseases
- 曾春典 Division of Cardiovascular Diseases
- Yi-Chih Wang Division of Cardiovascular Diseases
- - - Division of Cardiovascular Diseases
- Yen-Wen Wu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Po-Chao Hsu Division of Cardiovascular Diseases
- 溫文才 Division of Cardiovascular Diseases
- Tsung-Hsien Lin Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 鄭凱鴻 Division of Cardiovascular Diseases
- 顏學偉 Division of Cardiovascular Diseases
- 朱志生 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
600 participants
